P134 Cells

P134 cells · Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P134 Cells, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of P134 Cells in Recurrent Glioblastoma [Phase 1, Phase 2]